Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus

@article{Leung2011DelayedOT,
  title={Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus},
  author={Yiu-hong Leung and Wei Ling Lim and Mun Hoe Wong and Shuk-kwan Chuang},
  journal={Epidemiology and Infection},
  year={2011},
  volume={140},
  pages={814 - 817}
}
SUMMARY During the early phase of the influenza pandemic in 2009, all cases of laboratory-confirmed pandemic (H1N1) 2009 (pH1N1) infection required compulsory isolation in hospital. These cases were offered oseltamivir treatment and only allowed to be discharged from the hospital when three consecutive respiratory specimens were negative for the virus by reverse transcription–polymerase chain reaction (RT–PCR). We reviewed the case records of these patients to assess the viral shedding kinetics… 
Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age
TLDR
The mean duration of viral shedding generally increased with severity of clinical presentation, but it was found no evidence of longer shedding duration of influenza A(H1N1)pdm09 among children compared with adults, and the need for a standardised approach was highlighted.
Viral load dynamics in adult patients with A(H1N1)pdm09 influenza
TLDR
The dynamics of influenza A viral load in respiratory samples collected from adult A(H1N1)pdm09 influenza patients were investigated and resolution of cough and headache was correlated with viral load reduction in respiratory specimens.
Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010–2011
TLDR
HIV-infected persons on cART in this study shed influenza virus for a similar duration as that reported for HIV-uninfected people, and factors that may have affected influenza virus shedding were examined.
Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012–2014
TLDR
A longer duration of influenza virus shedding in HIV-infected individuals with low CD4 counts may suggest a possible increased risk for transmission or viral evolution in severely immunocompromised individuals.
Editorial commentary. "Late" treatment with neuraminidase inhibitors for severely ill patients with influenza: better late than never?
  • N. Lee, M. Ison
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
TLDR
It is unclear what constitutes optimal management in patients with severe influenza, particularly in the large proportion of individuals who present later in their course of illness.
Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households.
TLDR
Overall risk of polymerase chain reaction-confirmed infection among household contacts and the risk of secondary infection within households using an individual-based hazard model that accounted for tertiary transmission and infections occurring outside the household were found to be significantly higher for Victoria-lineage viruses.
Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.
Acute respiratory infections represent common diseases in childhood and a challenge to infection control, public heath, and the clinical management of patients and their families. Children are avid
Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009–15
TLDR
The evidence suggests NIs are likely safe to use in the general population; however, data for children and pregnant women are limited and knowledge gaps persist in specific populations such as Aboriginals, high-risk individuals and the elderly.
The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong
TLDR
There was a rapid and comprehensive research response to pH1N1 in Hong Kong, providing important information on the epidemiology of the novel virus with relevance internationally as well as locally.
...
1
2
...

References

SHOWING 1-10 OF 13 REFERENCES
Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
  • L. Ling, A. Chow, +8 authors Y. Leo
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
TLDR
Prolonged viral shedding was noted in young immunocompetent adults with mild pandemic influenza (H1N1) 2009 despite receipt of oseltamivir, which shortened the duration of viral shedding when prescribed during the first 3 days of illness.
Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China
TLDR
Treatment with oseltamivir was associated with a significantly reduced development of radiographically confirmed pneumonia and a shorter duration of fever and viral RNA shedding in Chinese patients with mild pandemic 2009 influenza A(H1N1) virus infection.
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
TLDR
Surveillance of the 2009 H1N1 virus in China shows that the majority of those infected have a mild illness, and the duration of infection may be shortened if oseltamivir is administered.
Early administration of oral oseltamivir increases the benefits of influenza treatment.
TLDR
The IMPACT study demonstrated that earlier initiation of oral oseltamivir therapy increased its therapeutic effects, which were seen at every time point of intervention and were progressive.
Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
TLDR
Early administration of oseltamivir and amantadine for the treatment of influenza increases the benefit of anti-influenza drugs and the type of influenza, the highest body temperature, and the time between the onset of symptoms and the start of treatment are independent factor that influence the duration of fever.
Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration.
Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009.
TLDR
This report describes the initial and ongoing investigation of the S-OIV outbreak in Mexico and confirms that several cases of severe respiratory illness laboratory confirmed as swine-origin influenza A (H1N1) virus (S-O IV) infection were communicated to the PAHO.
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.
TLDR
Concern exists that this new strain of swine influenza A (H1N1) is substantially different from human flu viruses, that a large proportion of the population might be susceptible to infection, and that the seasonal influenza vaccine H 1N1 strain might not provide protection.
Correlation of Pandemic (H1N1) 2009 Viral Load with Disease Severity and Prolonged Viral Shedding in Children
TLDR
Younger children may require a longer isolation period and more aggressive treatment than older children, and may need to be monitored more closely for signs of infection.
Primary and secondary syphilis - Jefferson county, Alabama, 2002-2007.
TLDR
The findings from this investigation indicate reemergence of syphilis among women and heterosexual men in Jefferson County, and public health officials in other areas should remain alert for similar epidemiologic shifts.
...
1
2
...